Thenew compounds were evaluated for the inhibition of S(RBD)/ACE2 interactionand reduction of the cytopathic effect of SARS-CoV-2 in Vero E6 cells.The most potent were further assessed for preventing infection fromthe original SARS-CoV-2 in vitro. The gene discussed is ACE2; the disease is infection.